Celltrion | 068270 - Ebit


Celltrion reported KRW20.08B in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -6.17M 4.22M Jun/2026
Celltrion KRW 20.08B 6.67B Jun/2026
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Moderna USD -815M 573M Jun/2026
Organon & Co USD 377M 86M Sep/2026
Revvity USD 126.14M 43.36M Jun/2026
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Viatris USD 73.7M 93.9M Jun/2026
Xeris Pharmaceuticals USD -24.15M 33.27M Jun/2026